Answers are grounded in this paper and cite their sources.
Based on azologization and structural simplification of the potent glucose transporter 1 (GLUT1) inhibitor BAY-876, nine novel azo compounds were designed, synthesized and evaluated towards their applicability as photoswitchable GLUT1 inhibitors. Eight candidates showed suitable photochemical properties, whereat the compounds reached a photostationary state (PSS365) between 96% cis and 87% cis while being largely present as trans isomers (between 99% and 76%) under ambient light. Moreover, the azo compounds did not give any hint of decomposition after multiple forth-and-back switching events. Biological investigations using recombinant and cancer-derived cell models demonstrated that the three cis isomers of PWH203 (1), PWH448 (2) and LLH003 (6) show remarkable GLUT1 inhibition while the corresponding trans isomers are more or less inactive. These results lay the groundwork towards improved targeting in cancer therapy, where GLUT1 inhibitors are only active in the irradiated target tissue while converting back to their inactive state when leaving this area.
No takes yet. Share an insight, caveat, or question.
Lochschmidt et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: